280. 巨大動静脈奇形(頚部顔面又は四肢病変) Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 29 / 薬物数 : 31 - (DrugBank : 15) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 163
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
68GA-NEB
Peking Union Medical College Hospital
2014 Phase 1 NCT02496013 China
Alpelisib
Murdoch Childrens Research Institute
2024 Phase 2 NCT05983159 Australia
Bevacizumab
University of California, San Francisco
2016 Phase 1 NCT02314377 United States
Bleomycin
Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
2016 - ChiCTR-IOR-16008047 China
2014 - ChiCTR-OOB-15007258 China
Blood sample
Fondation Ophtalmologique Adolphe de Rothschild
2022 - NCT04772963 France
Blood samples
Assistance Publique Hopitaux De Marseille
2013 - NCT01774916 France
Cobimetinib
University of Arkansas
2022 Phase 2 NCT05125471 United States
Dexmedetomidine
Nan Jiang
2016 - NCT03076099 China
Dexmedetomidine 1
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Dexmedetomidine 2
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Dexmedetomidine 3
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Doxycycline
University of California, San Francisco
2008 Phase 1 NCT00783523 United States
2004 Phase 1 NCT00243893 United States
Ethanol
Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
2018 - ChiCTR1800017616 China
2018 - ChiCTR1800015220 China
Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University
2020 - ChiCTR2000036597 China
2020 - ChiCTR2000036576 China
Haemoblock
Center for Vascular Pathology, Moscow
2020 Phase 4 NCT04999618 Russian Federation
Heparin sodium
Beijing Tiantan Hospital
2016 - NCT03306836 China
L04aa10
CHRU TOURS
2019 Phase 2 EUCTR2019-001530-33-FR France
Lipiodol® ultra fluid with surgical glues
Guerbet
2017 Phase 4 NCT02625389 India
Lovastatin
Beijing Tiantan Hospital
2021 Phase 2 NCT04297033 China
Mekinist
Cliniques universitaires Saint-Luc
- Phase 2 EUCTR2019-003573-26-BE Belgium
Minocycline
University of California, San Francisco
2004 Phase 1 NCT00243893 United States
Mirdametinib
Murdoch Childrens Research Institute
2024 Phase 2 NCT05983159 Australia
Normal saline
Nan Jiang
2016 - NCT03076099 China
Rapamune
CHRU TOURS
2019 Phase 2 EUCTR2019-001530-33-FR France
Rapamune 0.5 MG coated tablets
CHU Amiens
2014 Phase 2 EUCTR2011-000321-69-FR France
Rapamune 1 MG/ML oral solution
CHU Amiens
2014 Phase 2 EUCTR2011-000321-69-FR France
Sirolimus
Centre Hospitalier Universitaire, Amiens
2014 Phase 2 NCT02042326 Belgium;France
Gifu University
2017 - JPRN-UMIN000030522 Japan
Sirolimus 0,1% CRèME
CHRU TOURS
2019 Phase 2 EUCTR2018-001359-11-FR France
Sirolimus 1MG/ML
CHRU TOURS
2019 Phase 2 EUCTR2019-001530-33-FR France
Sufentanil
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Thalidomide
Northport Veterans Affairs Medical Center
2006 Phase 2 NCT00389935 United States
Xuanwu Hospital, Capital Medical University
2019 Phase 0 ChiCTR1900021901 China
Trametinib tablet
University Health Network, Toronto
2024 Phase 2 NCT06098872 Canada
Peking Union Medical College Hospital
2014 Phase 1 NCT02496013 China
Alpelisib
Murdoch Childrens Research Institute
2024 Phase 2 NCT05983159 Australia
Bevacizumab
University of California, San Francisco
2016 Phase 1 NCT02314377 United States
Bleomycin
Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
2016 - ChiCTR-IOR-16008047 China
2014 - ChiCTR-OOB-15007258 China
Blood sample
Fondation Ophtalmologique Adolphe de Rothschild
2022 - NCT04772963 France
Blood samples
Assistance Publique Hopitaux De Marseille
2013 - NCT01774916 France
Cobimetinib
University of Arkansas
2022 Phase 2 NCT05125471 United States
Dexmedetomidine
Nan Jiang
2016 - NCT03076099 China
Dexmedetomidine 1
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Dexmedetomidine 2
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Dexmedetomidine 3
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Doxycycline
University of California, San Francisco
2008 Phase 1 NCT00783523 United States
2004 Phase 1 NCT00243893 United States
Ethanol
Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
2018 - ChiCTR1800017616 China
2018 - ChiCTR1800015220 China
Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University
2020 - ChiCTR2000036597 China
2020 - ChiCTR2000036576 China
Haemoblock
Center for Vascular Pathology, Moscow
2020 Phase 4 NCT04999618 Russian Federation
Heparin sodium
Beijing Tiantan Hospital
2016 - NCT03306836 China
L04aa10
CHRU TOURS
2019 Phase 2 EUCTR2019-001530-33-FR France
Lipiodol® ultra fluid with surgical glues
Guerbet
2017 Phase 4 NCT02625389 India
Lovastatin
Beijing Tiantan Hospital
2021 Phase 2 NCT04297033 China
Mekinist
Cliniques universitaires Saint-Luc
- Phase 2 EUCTR2019-003573-26-BE Belgium
Minocycline
University of California, San Francisco
2004 Phase 1 NCT00243893 United States
Mirdametinib
Murdoch Childrens Research Institute
2024 Phase 2 NCT05983159 Australia
Normal saline
Nan Jiang
2016 - NCT03076099 China
Rapamune
CHRU TOURS
2019 Phase 2 EUCTR2019-001530-33-FR France
Rapamune 0.5 MG coated tablets
CHU Amiens
2014 Phase 2 EUCTR2011-000321-69-FR France
Rapamune 1 MG/ML oral solution
CHU Amiens
2014 Phase 2 EUCTR2011-000321-69-FR France
Sirolimus
Centre Hospitalier Universitaire, Amiens
2014 Phase 2 NCT02042326 Belgium;France
Gifu University
2017 - JPRN-UMIN000030522 Japan
Sirolimus 0,1% CRèME
CHRU TOURS
2019 Phase 2 EUCTR2018-001359-11-FR France
Sirolimus 1MG/ML
CHRU TOURS
2019 Phase 2 EUCTR2019-001530-33-FR France
Sufentanil
First Affiliated Hospital, Sun Yat-Sen University
2015 Phase 4 NCT02552459 China
Thalidomide
Northport Veterans Affairs Medical Center
2006 Phase 2 NCT00389935 United States
Xuanwu Hospital, Capital Medical University
2019 Phase 0 ChiCTR1900021901 China
Trametinib tablet
University Health Network, Toronto
2024 Phase 2 NCT06098872 Canada